Results 81 to 90 of about 291,220 (220)

[Managing of platelet transfusion refractoriness of haematological malignancies. Experience IPC-EFSAM.]

, 2014
International audienceThe platelet refractoriness is a complication of transfusion treatments potentially dramatic in onco-haematology. Chemo-treatment of haematological malignancies or packs of allogeneic bone marrow transplants require iterative ...
Ladaique, P, Dettori, I
core  

Sirolimus is effective for paediatric Evans syndrome and secondary autoimmune cytopenias: A retrospective cohort study

British Journal of Haematology, EarlyView.
Maggie McNeill, Camilla Cellarius, Nethmi Illamperuma, Rachelle Zipper, Clarisse Carcao, Jillian M. Baker, Sheila Butchart, Michelle Fantauzzi, Caroline Malcolmson, Reena Pabari, Diandra Rollan, Kathleen Qu, Manuel Carcao   +12 more
wiley   +1 more source

Molecular characterization of CD36 deficiency in blood donors of Middle Eastern and African origin reveals transcript‐level defects beyond genomic variants

Transfusion, EarlyView.
Abstract Background The increasing diversity of blood donor populations has created new challenges for transfusion services worldwide. The identification of donors lacking relevant high‐prevalence antigens is becoming increasingly important to ensure compatible blood products for alloimmunized patients and to support the development of rare donor ...
Sarah Petermann, Inga Stellmacher, Brigitte K. Flesch, Tanja Rehling, Irina Häcker, Marc F. Schetelig, Alexander Carbol, Lambros Kordelas   +7 more
wiley   +1 more source

Platelet Antibody Detection By Flow Cytometry: An Effective Method To Evaluate And Give Transfusional Support In Platelet Refractoriness

, 2015
Background: Immune platelet refractoriness is mainly caused by human leukocyte antigen antibodies (80- 90% of cases) and, to a lesser extent, by human platelet antigen antibodies.
Goncalez A.C., Barjas-Castro M.L., Martinelli B.M., Avelino T.M., Bub C.B., Castro V.   +5 more
core   +1 more source

Evaluation of the provision of crossmatch compatible platelets for haematology patients who have acquired non-immune refractoriness [PDF]

, 2022
Platelet demand is unpredictable and will relate to case mix, programmes of treatment requiring intensive platelet support and health service activity.
Reynolds, Samantha J.
core  

Severe Thrombocytopenia Associated With Glucagon‐Like‐1 Receptor Agonists (GPL‐1RA): A SONAR Report

Diabetes, Obesity and Metabolism, EarlyView.
Charles L. Bennett, Chadi Nabhan, Demir Uslu, Yogitha Dadi, David Aboulafia, Barbara Senger, Joseph Magagnoli, Kelvin Rojas, Gurdeep Singh, Linda Martin, Edward Smith, Samuel Ruder, Chien‐Hsiang Weng, Nikhil Uppal, Mia Lynch, James B. Bussel   +15 more
wiley   +1 more source

Passive acquisition of hepatitis B virus antibodies after allogeneic hematopoietic cell transplantation

Transfusion, EarlyView.
Abstract Background Newly positive hepatitis B virus (HBV) serologic results after allogeneic hematopoietic cell transplantation (HCT) may reflect passive antibody transfer from blood‐derived products rather than HBV infection. We investigated the incidence and temporal patterns of hepatitis B surface antibody (anti‐HBs) and antibody to hepatitis B ...
Takaaki Konuma, Maki Monna‐Oiwa, Etsuko Nagai, Seiko Kato, Shohei Andoh, Junichi Kuroda, Satoshi Takahashi, Yasuhito Nannya   +7 more
wiley   +1 more source

Platelet function analysed by ROTEM platelet in cardiac surgery after cardiopulmonary bypass and platelet transfusion

, 2020
Objectives The aim of this study was to investigate whether ROTEM platelet can provide additional information to the traditional ROTEM analysis to guide treatment with platelet transfusions in cardiac surgery and to identify factors triggering platelet ...
Agneta Wikman, Lindvall, Gabriella,, Kjellberg, Gunilla,, Manne Holm, Jan van der Linden, Linden, Jan,, Gunilla Kjellberg, Wikman, Agneta,, Gunilla Gryfelt, Holm, Manne,, Gabriella Lindvall, Gryfelt, Gunilla,, Kjellberg, G, Holm, M,, Wikman, A,, Lindvall, G,, Linden, J, Gryfelt, G   +17 more
core   +1 more source

Prospective multi‐centre haemovigilance of amotosalen and ultraviolet A‐treated platelets and plasma in routine clinical use

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Amotosalen/ultraviolet A light (A/UVA) pathogen‐reduced platelets and plasma have been approved for clinical use in Europe since 2003 and 2006, respectively. Cross‐sectional safety haemovigilance (HV) studies have been conducted in 29 hospitals in 15 European countries since 2003. This report describes the most recent
Magdalena Łętowska, Anna Krukowska, Dariusz Piotrowski, Zofia Przybylska, Konrad Rosskopf, Angelo Ostuni, Margherita Giannoccaro, Rossella Procacci, Christine Ernst, Johannes Irsch, Laurence Corash, Richard J. Benjamin, Kathy Liu, Linh Dinh, John P. Pitman   +14 more
wiley   +1 more source

Immune platelet transfusion refractoriness associated with anti‐CD36 alloimmunisation in a Brazilian patient with platelet CD36 deficiency

Vox Sanguinis, EarlyView.
Abstract Background and Objectives Immune platelet transfusion refractoriness (PTR) is usually mediated by anti‐HLA class I antibodies; immunisation against CD36 (platelet glycoprotein IV [GPIV]) is relatively rare. Platelet CD36 deficiency shows marked ethnic variability and is seldom reported in admixed Latin American populations.
Rayane Dayse Alves Conserva, Luiz Frederico Bezerra Honorato Junior, Ana Paula Hitomi Yokoyama, Thiago Henrique Costa, Luis Henrique Cardoso Fedeli, Ana Cynira Franco Marret, Eduardo Perez Bastos, Fabio Pires de Souza Santos, Luana Nobrega Costa, Livia Chiosini de Nadai, Carolina Bonet‐Bub, Jose Mauro Kutner   +11 more
wiley   +1 more source